Frank-Raue K, Leidig-Bruckner G, Lorenz A, Rondot S, Haag C, Schulze E, Büchler M, Raue F
Endokrinologische Gemeinschaftspraxis und molekulargenetisches Labor, Heidelberg.
Dtsch Med Wochenschr. 2011 Sep;136(38):1889-94. doi: 10.1055/s-0031-1286358. Epub 2011 Sep 13.
The challenge in diagnosing primary hyperparathyroidism (HPT) is to detect hereditary cases before first surgery. About 5% of cases are hereditary and integral component of multiple endocrine neoplasia type 1 and 2 (MEN1/MEN2), hyperparathyroidism-jaw tumor syndrome (HPT-JT), familial hypocalciuric hypercalcemia (FHH), and familial isolated hyperparathyroidism (FIHPT). Aim of this study was to evaluate similarities and differences in hereditary varieties of HPT.
80 patients with hereditary HPT were evaluated in a retrospective analysis between 1980 and 2010 concerning clinical findings, family history, therapy, biochemical and molecular-genetic findings and follow-up.
80 patients with hereditary HPT are described, 52 belonged to MEN1, 15 to MEN2, 7 to HPT-JT, 4 to FHH and 2 to FIHPT kindreds. Penetrance of HPT was highest in MEN1 (85%), followed by HPT-JT (64%), FHH (28.5%), and MEN2 (8%). Youngest age at diagnosis of HPT was 7 and 16 years in the MEN2/HPT-JT group. Serum Calcium was highest in the HPT-JT group (3.6 mM), recurrencies of HPT were highest in the MEN1 group (40.5%). Parathyroid cancer solely occurred in the HPT-JT group. In single cases HPT occurs in FHH.
Among the different varieties of hereditary HPT MEN1-HPT is most frequent and carries the utmost recurrence rate. Early diagnosis of HPT-JT syndrome is important because of the occurrence of parathyroid cancer. Single cases of HPT in FHH are described. Preoperative diagnosis of hereditary HPT has therapeutic consequences concerning extent of surgery and implications concerning patient and family care.
诊断原发性甲状旁腺功能亢进症(HPT)的挑战在于在首次手术前检测出遗传性病例。约5%的病例为遗传性,是多内分泌腺瘤1型和2型(MEN1/MEN2)、甲状旁腺功能亢进-颌骨肿瘤综合征(HPT-JT)、家族性低钙血症性高钙血症(FHH)以及家族性孤立性甲状旁腺功能亢进症(FIHPT)的组成部分。本研究的目的是评估HPT遗传性类型的异同。
对1980年至2010年间80例遗传性HPT患者进行回顾性分析,内容包括临床表现、家族史、治疗、生化及分子遗传学检查结果以及随访情况。
描述了80例遗传性HPT患者,其中52例属于MEN1,15例属于MEN2,7例属于HPT-JT,4例属于FHH,2例属于FIHPT家系。HPT在MEN1中的外显率最高(85%),其次是HPT-JT(64%)、FHH(28.5%)和MEN2(8%)。MEN2/HPT-JT组诊断HPT的最年轻年龄为7岁和16岁。HPT-JT组的血清钙最高(3.6 mM),MEN1组HPT的复发率最高(40.5%)。甲状旁腺癌仅发生在HPT-JT组。FHH中个别病例也会出现HPT。
在遗传性HPT的不同类型中,MEN1-HPT最为常见且复发率最高。由于甲状旁腺癌的发生,HPT-JT综合征的早期诊断很重要。描述了FHH中HPT的个别病例。遗传性HPT的术前诊断对手术范围以及患者和家庭护理具有治疗意义。